NICE News for GEP NET Patients

It has been a really long journey to get to this day.  We are delighted to share with you the news that the National Institute for Health Care Excellence (NICE) has recommended Lutetium (177Lu) oxodotreotide, within its marketing authorisation, as an option...

NET Patient Foundation launches new campaign Walk for NETs

We’re excited to launch our brand new campaign… Walk for NETs!   This summer we want as many people as possible to hold a Walk for NETs to help us continue providing community support to anyone affected by Neuroendocrine Cancer. There are over 4,000 people...

NETs Research Road Trip

NET Patient Foundation has joined together with Association for Multiple Endocrine Neoplasia Disorders, AMEND, to investigate the research that is happening in the UK for NETs.   For the second leg of the research road trip we visited the UCL Cancer...